RESUMEN
This 2-yr study evaluated the growth and puberty attainment of Bos indicus-influenced beef heifers offered 2 different postweaning concentrate supplementation amounts and delivery frequencies. On day 0 of each year, 64 Brangus crossbred heifers were stratified by initial body weight (BW) and age (mean = 244 ± 22 kg; 314 ± 17 d) and assigned into 1 of 16 bahiagrass pastures (4 heifers/pasture/yr). Treatments were randomly assigned to pastures in a 2 × 2 factorial design (4 pastures/treatment/yr) and consisted of concentrate dry matter (DM) supplementation at 1.25% or 1.75% of BW which were offered either daily (7×) or 3 times weekly (3×) for 168 d. On day 56 of each year, heifers were assigned to an estrus synchronization protocol consisting of intravaginal controlled internal drug release (CIDR) insertion on day 56, CIDR removal on day 70, i.m. injection of 25 mg of prostaglandin F2α (PGF2α) on day 86, and i.m. injection of 100 µg of gonadotropin-releasing hormone and timed-AI at 66 h after PGF2α injection (day 89). Heifers were exposed to Angus bulls from day 89 to 168 (1 bull/pasture). Pregnancy diagnosis was assessed on day 213 of each year. Supplementation amount × frequency effects were not detected (P ≥ 0.12) for any variable, except for plasma concentrations of glucose (P = 0.10) and urea nitrogen (PUN; P = 0.01). Herbage mass, herbage allowance, and nutritive value did not differ (P ≥ 0.12) among treatments. Increasing supplementation DM amount from 1.25% to 1.75% of BW increased (P ≤ 0.05) plasma concentrations of insulin-like growth factor 1 (IGF-1), overall average daily gain (ADG), final BW, percentage of pubertal heifers on day 89, pregnancy and calving percentages, and percentage of heifers calving within the first 21 d of the calving season. However, reducing the supplementation frequency from daily to 3× weekly, regardless of supplementation amount, did not impact overall pregnancy and calving percentages (P ≥ 0.42), but caused (P ≤ 0.05) fluctuations in plasma concentrations of insulin and IGF-1 and decreased (P ≤ 0.03) overall ADG, final BW, puberty attainment on days 56, 89, and 168, and percentage of heifers calving during the first 21 d of the calving season. Hence, increasing the supplement DM amount did not prevent the negative effects of reducing the frequency of supplementation (3× vs. 7× weekly) on growth and reproduction of replacement Bos indicus-influenced beef heifers.
Asunto(s)
Bovinos/fisiología , Suplementos Dietéticos/análisis , Dinoprost/administración & dosificación , Ingestión de Alimentos , Hormona Liberadora de Gonadotropina/administración & dosificación , Reproducción/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Bovinos/crecimiento & desarrollo , Sincronización del Estro , Femenino , Factor I del Crecimiento Similar a la Insulina/análisis , Factor I del Crecimiento Similar a la Insulina/genética , Masculino , Valor Nutritivo , Paspalum , Embarazo , Estaciones del Año , Maduración Sexual/efectos de los fármacosRESUMEN
A 2-yr study evaluated the growth and postvaccination immune response of beef calves born from heifers offered no supplementation or pre- and postpartum supplementation of sugarcane molasses + urea with or without methionine hydroxy analog (MHA). On day 0 of each year (57 ± 5 d prepartum), Brangus crossbred beef heifers (n = 36/yr; 20 to 22 mo of age) were stratified by their initial body weight (BW; 396 ± 24.1 kg) and body condition score (BCS; 5.6 ± 0.43) and randomly allocated into 1 of 12 bahiagrass (Paspalum notatum) pastures (3 heifers/pasture). Treatments were randomly assigned to pastures (4 pastures/treatment/yr) and consisted of no supplementation (NOSUP) and supplementation of sugarcane molasses + urea (7.2 kg of DM/heifer/wk) with (MOL+) or without (MOL-) fortification with 105 g/heifer/wk of MHA. Treatments were provided from 57 ± 5 d prepartum until 17 ± 5 d postpartum (day 0 to 74). On day 74, all heifer-calf pairs were combined and managed as a single group until the end of the breeding season (day 237). Calves were early weaned at 89 ± 5 d of age (day 147), limit-fed at 3.5% of BW (DM basis) in drylot until day 201, and vaccinated against respiratory disease pathogens on days 160 and 188. Prepartum BCS on day 44 did not differ (P = 0.26) between MOL+ and MOL- heifers but both groups had greater (P < 0.0001) BCS than NOSUP heifers. Plasma concentrations of l-methionine on day 44 were the greatest (P ≤ 0.04) for MOL+ heifers and did not differ (P = 0.40) between NOSUP vs. MOL- heifers. Calf birth BW did not differ (P = 0.13) among treatments. Calf average daily gain (ADG) from birth to day 201 did not differ (P ≥ 0.17) between MOL+ vs. MOL- calves, but both groups had greater (P ≤ 0.05) ADG from birth to day 201 than NOSUP calves. Calf postvaccination plasma concentrations of glucose, cortisol, and haptoglobin did not differ among treatments (P ≥ 0.13). However, plasma concentrations of IGF-1 on day 167 and the overall positive vaccine seroconversion did not differ (P ≥ 0.18) between MOL- and MOL+ calves, but both were greater (P ≤ 0.04) compared with NOSUP calves. Hence, maternal supplementation of sugarcane molasses + urea increased BCS at calving and offspring BW gain and response to vaccination against respiratory pathogens compared with no maternal supplementation. MHA inclusion into maternal supplements effectively increased maternal plasma l-methionine concentrations but did not enhance maternal BCS at calving and offspring growth and postvaccination immune response.
Asunto(s)
Bovinos/fisiología , Suplementos Dietéticos/análisis , Ingestión de Energía , Vacunación/veterinaria , Animales , Peso Corporal , Cruzamiento , Bovinos/crecimiento & desarrollo , Bovinos/inmunología , Dieta/veterinaria , Femenino , Factor I del Crecimiento Similar a la Insulina/análisis , Metionina/análogos & derivados , Metionina/análisis , Melaza , Parto , Periodo Posparto , Embarazo , Distribución Aleatoria , Saccharum , Estaciones del Año , DesteteRESUMEN
Two experiments evaluated the effects of concentrate amount and monensin inclusion on growth and physiological parameters of early-weaned beef calves consuming warm-season grasses in drylot (Exp. 1) and pastures (Exp. 2). In both experiments, treatments consisted of two concentrate DM amounts (1 or 2% of BW) and two inclusion rates of monensin (0 or 20 mg of monensin/kg of total DM intake). In Exp. 1, 48 Angus × Brahman crossbred early-weaned (EW) beef calves (initial age = 90 ± 13 d; initial BW = 83 ± 12 kg) were distributed in 12 drylot pens (four calves per pen; three pens per treatment) and provided stargrass (Cynodon nlemfuensis) hay (9% CP and 52% IVDOM) at amounts to ensure 10% DM refusals for 56 d. In Exp. 2, 36 Angus × Brahman crossbred EW heifer calves (initial BW = 171 ± 15 kg) were randomly allocated into one of 12 bahiagrass (Paspalum notatum) pastures on a continuous and fixed stocking rate (1 ha and three heifers per pasture; three pastures per treatment) and received daily supplementation of their respective treatments for 84 d. In both experiments, effects of monensin inclusion × concentrate amount were not detected for any variable (P ≥ 0.14), but overall ADG and plasma IGF-1 concentrations were greater (P ≤ 0.05), whereas fecal coccidia egg counts tended (P = 0.09; Exp. 1) or were less (P = 0.05; Exp. 2) for calves offered concentrate with vs. without monensin inclusion. Calves offered concentrate at 2% of BW had greater (P ≤ 0.05) overall ADG (Exps. 1 and 2), herbage mass (Exp. 2 only), in vivo apparent digestibility, total DMI and plasma concentrations of glucose and IGF-1 (Exp. 1 only), less forage DM intake (Exp. 1 only), and no effects on fecal coccidia egg counts (Exps. 1 and 2) compared to calves offered concentrate at 1% of BW. Increasing concentrate amount is an effective management practice to increase ADG and decrease forage DMI in early-weaned calves consuming warm-season grasses, whereas the decrease in fecal coccidia egg count and additional ADG provide evidence that monensin should be supplied to early-weaned calves grazing warm-season pastures and receiving concentrate at 1% of BW or above.